---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-308673"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2021-10-27T23:59:59+00:00"
generated_at: "2026-06-28T17:34:49.968771+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics appoints Gary Winer and Lisa Giles to board of directors

## Summary
- HCW Biologics appointed Gary Winer as Class I director and Lisa Giles as Class II director, effective Oct 25, 2021.
- Both new directors appointed to audit and compensation committees; Dr. Hing Wong stepped down from audit committee.
- Winer was CEO of ORGENTEC Diagnostika until Sept 2021; Giles is founder/CEO of Giles & Associates Consultancy.
- Directors compensated per Non-Employee Director Compensation Policy, pro-rated; indemnification agreements to be signed.

## SEC filing metadata
- accession: 0001193125-21-308673
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2021-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/d53143d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-308673
- JSON: https://secwatch.observer/filing/0001193125-21-308673.json
- Plain text: https://secwatch.observer/filing/0001193125-21-308673.txt

## Key facts
- Executive change
  Lisa Giles was appointed as Director at HCW Biologics Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Gary Winer as a Class I member of the Board and Lisa Giles as a Class II member of the Board, in each case effective October 25, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm
- Executive change
  Gary Winer was appointed as Director at HCW Biologics Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Gary Winer as a Class I member of the Board and Lisa Giles as a Class II member of the Board, in each case effective October 25, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.